AI is not merely accelerating life sciences and medtech — it is fundamentally reshaping how research is conducted, therapies are developed, care is delivered, and patients engage with the system, with major implications for competitiveness, public trust, health equity, and economic resilience. Building on insights from the Life Sciences and MedTech Horizons work, this session will convene public- and private-sector leaders to align on a shared vision for the sector’s evolving role and identify the conditions needed to ensure AI-driven transformation delivers tangible benefits for people while strengthening industries and economies.